CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01
Authors
AA Holder
AE Dent
+66 more
AR Dluzewski
AW Stowers
AW Stowers
B Genton
BA Okech
Ben Andagalu
Bernhards Ogutu
BR Ogutu
Brent House
CA Darko
Carter Diggs
CD Galamo
CF Ockenhouse
Christian F Ockenhouse
D Courtin
D Gray Heppner
DG Heppner Jr
Donna Tosh
E Angov
E Malkin
Elke Bergmann-Leitner
ES Bergmann-Leitner
ES Bergmann-Leitner
Evelina Angov
Farhat Khan
FJ McCallum
Godfrey Allan Otieno
GS Hui
JA Lyon
JA Stoute
James Cummings
Jason Bennett
JF Cummings
Joe Cohen
John Waitumbi
KE Kester
KE Persson
L Renia
Lisa Ware
Lori Miller
Lorraine Soisson
Lucas Otieno
MA Thera
Margaret Koech
Marie-Claude Dubois
Mark Polhemus
MD Spring
ME Polhemus
Meng Shi
Michele D Spring
MR Withers
Nancy Richie
Nekoye Otsyula
Olivier Godeaux
PD Crompton
R Perraut
RD Ellis
RI Nwuba
RS McIntosh
RTS,S Clinical Trial Partnership
S Singh
SP Chang
TF De Koning-Ward
V Udhayakumar
W Ripley Ballou
Walter Otieno
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2F1475-2875-1...
Last time updated on 01/04/2019